Universal erythroderma, KELA reimbursement

L12_ERYTHRO_KELA

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 134

1 out of 7 registries used, show all original rules.

459

diagram downward connector

Check minimum number of events None

459

diagram downward connector

Include endpoints None

459

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

445

diagram downward connector
L12_ERYTHRO_KELA

Control definitions

Control exclude L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 445 156 289
Unadjusted prevalence (%) 0.11 0.07 0.16
Mean age at first event (years) 48.78 47.31 49.57

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_ERYTHRO_KELA – Universal erythroderma, KELA reimbursement
GWS hits: 2

Survival analyses between endpoints

Plot

before Universal erythroderma, KELA reimbursement
after Universal erythroderma, KELA reimbursement

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Universal erythroderma, KELA reimbursement

Endpoint not on priority list, no data to show.